Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Emergency use authorization Experimental Vaccine Apr/02/2021 33 0
mRNA-1273 Emergency use authorization Experimental Vaccine Apr/02/2021 18 0
GC376 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/01/2021 11 0
4-[2-(2-Benzyloxycarbonylamino-3-t-butoxy-butyrylamino)-4-methyl-pentanoylamino]-5-(2-oxo-pyrrolidin-3-yl)-pent-2-enoic acid ethyl ester Potential treatment - pre-clinical evidence Experimental Antiviral Apr/01/2021 1 0
N-[(2S)-1-[[(3S)-1-(benzenesulfonyl)-5-phenylpentan-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methylpiperazine-1-carboxamide Potential treatment - pre-clinical evidence Experimental Antiviral Mar/31/2021 1 0
MXB-9 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/31/2021 1 0
MXB-4 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/31/2021 1 0
ChAdOx1 nCoV-19 Emergency use authorization Experimental Vaccine Mar/30/2021 11 1
rLVS ΔcapB/SCoV2 MN Potential treatment - pre-clinical evidence Experimental Vaccine Mar/30/2021 1 0
Convalescent plasma Emergency use authorization Experimental Antiviral Mar/30/2021 34 6